These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23496132)

  • 21. Gout in 2006: the perfect storm.
    Terkeltaub R
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):82-6. PubMed ID: 17121496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperuricaemia and gout.
    Shipley M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):229-33. PubMed ID: 21949921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal urate transport.
    Mount DB; Kwon CY; Zandi-Nejad K
    Rheum Dis Clin North Am; 2006 May; 32(2):313-31, vi. PubMed ID: 16716882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperuricemia, gout and the metabolic syndrome.
    Puig JG; Martínez MA
    Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of
    Toyoda Y; Takada T; Saito H; Hirata H; Ota-Kontani A; Kobayashi N; Tsuchiya Y; Suzuki H
    NPJ Sci Food; 2020; 4():3. PubMed ID: 32047858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Human renal urate transpoter URAT1 mediates the transport of salicylate].
    Ohtsu N; Anzai N; Fukutomi T; Kimura T; Sakurai H; Endou H
    Nihon Jinzo Gakkai Shi; 2010; 52(4):499-504. PubMed ID: 20560471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insights into the epidemiology of gout.
    Doherty M
    Rheumatology (Oxford); 2009 May; 48 Suppl 2():ii2-ii8. PubMed ID: 19447779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperuricemia, gout and the kidney.
    Gibson T
    Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China.
    Guan M; Zhang J; Chen Y; Liu W; Kong N; Zou H
    Scand J Rheumatol; 2009; 38(4):276-81. PubMed ID: 19306160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT; Pillinger MH
    Bull NYU Hosp Jt Dis; 2009; 67(3):285-90. PubMed ID: 19852752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of control and self-medication of chronic gout in a developing country. Outcome after 10 years.
    Darmawan J; Rasker JJ; Nuralim H
    J Rheumatol; 2003 Nov; 30(11):2437-43. PubMed ID: 14677190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular identification of a renal urate anion exchanger that regulates blood urate levels.
    Enomoto A; Kimura H; Chairoungdua A; Shigeta Y; Jutabha P; Cha SH; Hosoyamada M; Takeda M; Sekine T; Igarashi T; Matsuo H; Kikuchi Y; Oda T; Ichida K; Hosoya T; Shimokata K; Niwa T; Kanai Y; Endou H
    Nature; 2002 May; 417(6887):447-52. PubMed ID: 12024214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.
    Hamada T; Ichida K; Hosoyamada M; Mizuta E; Yanagihara K; Sonoyama K; Sugihara S; Igawa O; Hosoya T; Ohtahara A; Shigamasa C; Yamamoto Y; Ninomiya H; Hisatome I
    Am J Hypertens; 2008 Oct; 21(10):1157-62. PubMed ID: 18670416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout).
    Becker MA
    Rheum Dis Clin North Am; 1988 Aug; 14(2):377-94. PubMed ID: 3051156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What do I need to know about gout?
    Becker MA; Ruoff GE
    J Fam Pract; 2010 Jun; 59(6 Suppl):S1-8. PubMed ID: 20544070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperuricemia and gout: new concepts in diagnosis and management.
    Doghramji PP; Wortmann RL
    Postgrad Med; 2012 Nov; 124(6):98-109. PubMed ID: 23322143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.